{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:48:09Z","timestamp":1791910089025,"version":"4.3.4"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Chem Res"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00044-025-03518-x","type":"journal-article","created":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T09:48:11Z","timestamp":1767433691000},"page":"278-303","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Advances in quercetin-based therapeutics for breast cancer: natural, synthetic, and nanotechnology-driven approaches"],"prefix":"10.1007","volume":"35","author":[{"family":"Shagufta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irshad","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila Zeyad","family":"Bazbouz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Areej W.","family":"Eissa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salma","family":"Abdellatif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,3]]},"reference":[{"key":"3518_CR1","unstructured":"World Health Organization. Breast cancer. 2025. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/breast-cancer. Accessed 20 Dec 2025."},{"key":"3518_CR2","doi-asserted-by":"crossref","unstructured":"Arzanova E, Mayrovitz HN. The epidemiology of breast cancer. In: Mayrovitz HN (ed) Breast Cancer. Exon Publications, Brisbane; 2022. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK583819\/. Accessed 20 Dec 2025.","DOI":"10.36255\/exon-publications-breast-cancer-epidemiology"},{"key":"3518_CR3","doi-asserted-by":"publisher","first-page":"375","DOI":"10.2147\/JEP.S528132","volume":"17","author":"IA Al Khalily","year":"2025","unstructured":"Al Khalily IA, Megantara S, Aulifa DL. Targeting molecular pathways in breast cancer using plant-derived bioactive compounds: a comprehensive review. J Exp Pharmacol. 2025;17:375\u2013401. https:\/\/doi.org\/10.2147\/JEP.S528132.","journal-title":"J Exp Pharmacol"},{"key":"3518_CR4","doi-asserted-by":"publisher","first-page":"7732","DOI":"10.3390\/ijms23147732","volume":"23","author":"MY Park","year":"2022","unstructured":"Park MY, Kim Y, Ha SE, Kim HH, Bhosale PB, Abusaliya A, et al. Function and application of flavonoids in breast cancer. Int J Mol Sci. 2022;23:7732 https:\/\/doi.org\/10.3390\/ijms23147732.","journal-title":"Int J Mol Sci"},{"key":"3518_CR5","doi-asserted-by":"publisher","first-page":"5377","DOI":"10.3390\/molecules26175377","volume":"26","author":"M Dias","year":"2021","unstructured":"Dias M, Pinto D, Silva A. Plant flavonoids: chemical characteristics and biological activity. Molecules. 2021;26:5377 https:\/\/doi.org\/10.3390\/molecules26175377.","journal-title":"Molecules"},{"key":"3518_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.crphar.2023.100167","volume":"6","author":"S Mir","year":"2023","unstructured":"Mir S, Dar A, Hamid L, Nisar N, Malik J, Ali T, et al. Flavonoids as promising molecules in cancer therapy: an insight. Curr Res Pharmacol Drug Discov. 2023;6:100167. https:\/\/doi.org\/10.1016\/j.crphar.2023.100167.","journal-title":"Curr Res Pharmacol Drug Discov"},{"key":"3518_CR7","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.3390\/cancers12061498","volume":"12","author":"A L\u00ed\u0161kov\u00e1","year":"2020","unstructured":"L\u00ed\u0161kov\u00e1 A, Koklesov\u00e1 L, Samec M, \u0160mejkal K, Samuel S, Varghese E, et al. Flavonoids in cancer metastasis. Cancers. 2020;12:1498 https:\/\/doi.org\/10.3390\/cancers12061498.","journal-title":"Cancers"},{"key":"3518_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112442","volume":"146","author":"H Slika","year":"2022","unstructured":"Slika H, Mansour H, Wehbe N, Nasser S, Iratni R, Nasrallah G, et al. Therapeutic potential of flavonoids in cancer: ROS-mediated mechanisms. Biomed Pharmacother. 2022;146:112442. https:\/\/doi.org\/10.1016\/j.biopha.2021.112442.","journal-title":"Biomed Pharmacother"},{"key":"3518_CR9","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3390\/cancers11010028","volume":"11","author":"M Abotaleb","year":"2018","unstructured":"Abotaleb M, Samuel S, Varghese E, Varghese S, Kubatka P, L\u00ed\u0161kov\u00e1 A, et al. Flavonoids in cancer and apoptosis. Cancers. 2018;11:28 https:\/\/doi.org\/10.3390\/cancers11010028.","journal-title":"Cancers"},{"key":"3518_CR10","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.3390\/ijms20133177","volume":"20","author":"M Reyes-Farias","year":"2019","unstructured":"Reyes-Farias M, Carrasco-Pozo C. The anti-cancer effect of quercetin: molecular implications in cancer metabolism. Int J Mol Sci. 2019;20:3177 https:\/\/doi.org\/10.3390\/ijms20133177.","journal-title":"Int J Mol Sci"},{"key":"3518_CR11","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3997190","volume":"2022","author":"G Wang","year":"2022","unstructured":"Wang G, Wang Y, Yao L, Gu W, Zhao S, Shen Z, et al. Pharmacological activity of quercetin: an updated review. Evid Based Complement Altern Med. 2022;2022:3997190. https:\/\/doi.org\/10.1155\/2022\/3997190.","journal-title":"Evid Based Complement Altern Med"},{"key":"3518_CR12","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.3390\/molecules27082498","volume":"27","author":"Deepika","year":"2022","unstructured":"Deepika, Maurya PK. Health benefits of quercetin in age-related diseases. Molecules. 2022;27:2498 https:\/\/doi.org\/10.3390\/molecules27082498.","journal-title":"Molecules"},{"key":"3518_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.943321","volume":"13","author":"Z Cui","year":"2022","unstructured":"Cui Z, Zhao X, Amevor FK, Du X, Wang Y, Li D, et al. Therapeutic application of quercetin in aging-related diseases: SIRT1 as a potential mechanism. Front Immunol. 2022;13:943321. https:\/\/doi.org\/10.3389\/fimmu.2022.943321.","journal-title":"Front Immunol"},{"key":"3518_CR14","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s10787-019-00660-y","volume":"28","author":"N Kasiri","year":"2020","unstructured":"Kasiri N, Rahmati M, Ahmadi L, Eskandari N, Motedayyen H. Therapeutic potential of quercetin on human breast cancer in different dimensions. Inflammopharmacology. 2020;28:39\u201362. https:\/\/doi.org\/10.1007\/s10787-019-00660-y.","journal-title":"Inflammopharmacology"},{"key":"3518_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1483459","volume":"15","author":"L Fang","year":"2024","unstructured":"Fang L, Gao D, Wang T, Zhao H, Zhang Y, Wang S. From nature to clinic: quercetin\u2019s role in breast cancer immunomodulation. Front Immunol. 2024;15:1483459. https:\/\/doi.org\/10.3389\/fimmu.2024.1483459.","journal-title":"Front Immunol"},{"key":"3518_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117463","volume":"248","author":"M Ezzati","year":"2020","unstructured":"Ezzati M, Yousefi B, Velaei K, Safa A. A review on anti-cancer properties of quercetin in breast cancer. Life Sci. 2020;248:117463. https:\/\/doi.org\/10.1016\/j.lfs.2020.117463.","journal-title":"Life Sci"},{"key":"3518_CR17","doi-asserted-by":"publisher","first-page":"e0330624","DOI":"10.1371\/journal.pone.0330624","volume":"20","author":"D Mustafov","year":"2025","unstructured":"Mustafov D, Siddiqui SS, Shagufta, Ahmad I, Charlton J, Gkantalis J, et al. New chalcone compound exhibits microRNA-mediated anticancer properties in glioblastoma. PLoS One. 2025;20:e0330624. https:\/\/doi.org\/10.1371\/journal.pone.0330624.","journal-title":"PLoS One"},{"key":"3518_CR18","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1007\/s00044-025-03411-7","volume":"34","author":"Shagufta","year":"2025","unstructured":"Shagufta, Ahmad I, Bazbouz LZ, et al. Pharmacological significance of palbociclib and its derivatives in cancer treatment and prevention: an update. Med Chem Res. 2025;34:1237\u20131252. https:\/\/doi.org\/10.1007\/s00044-025-03411-7.","journal-title":"Med Chem Res"},{"key":"3518_CR19","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1080\/17568919.2025.2479418","volume":"17","author":"Shagufta","year":"2025","unstructured":"Shagufta, Ahmad I, Nasar NA, Zerin S. Designing molecular hybrids as novel breast cancer therapeutics. Future Med Chem. 2025;17:857\u2013859. https:\/\/doi.org\/10.1080\/17568919.2025.2479418.","journal-title":"Future Med Chem"},{"key":"3518_CR20","doi-asserted-by":"publisher","first-page":"31789","DOI":"10.1021\/acsomega.4c01634","volume":"9","author":"D Mustafov","year":"2024","unstructured":"Mustafov D, Siddiqui SS, Kukol A, Lambrou GI, Shagufta, Ahmad I, et al. MicroRNA-dependent mechanisms underlying the function of a \u03b2-amino carbonyl compound in glioblastoma cells. ACS Omega. 2024;9:31789\u201331802. https:\/\/doi.org\/10.1021\/acsomega.4c01634.","journal-title":"ACS Omega"},{"key":"3518_CR21","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1039\/D4MD00191J","volume":"15","author":"Shagufta","year":"2024","unstructured":"Shagufta, Ahmad I, Nelson DJ, Hussain MI, Nasar NA. Potential of covalently linked tamoxifen hybrids for cancer treatment: recent update. RSC Med Chem. 2024;15:1877\u20131898. https:\/\/doi.org\/10.1039\/D4MD00191J.","journal-title":"RSC Med Chem"},{"key":"3518_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1254911","volume":"14","author":"MS Ahmad","year":"2023","unstructured":"Ahmad MS, Braoudaki M, Patel H, Ahmad I, Shagufta, Siddiqui SS. Novel Siglec-15\u2013Sia axis inhibitor leads to colorectal cancer cell death by targeting miR-6715b-3p and oncogenes. Front Immunol. 2023;14:1254911. https:\/\/doi.org\/10.3389\/fimmu.2023.1254911.","journal-title":"Front Immunol"},{"key":"3518_CR23","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1039\/D2MD00356B","volume":"14","author":"Shagufta","year":"2023","unstructured":"Shagufta, Ahmad I. Therapeutic significance of molecular hybrids for breast cancer research and treatment. RSC Med Chem. 2023;14:218\u2013238. https:\/\/doi.org\/10.1039\/D2MD00356B.","journal-title":"RSC Med Chem"},{"key":"3518_CR24","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1039\/C9MD00514J","volume":"11","author":"Shagufta","year":"2020","unstructured":"Shagufta, Ahmad I, Mathew S, Rehman S. Recent progress in selective estrogen receptor downregulators (SERDs) for the treatment of breast cancer. RSC Med Chem. 2020;11:438\u2013454. https:\/\/doi.org\/10.1039\/C9MD00514J.","journal-title":"RSC Med Chem"},{"key":"3518_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ica.2020.119521","volume":"506","author":"Shagufta","year":"2020","unstructured":"Shagufta, Ahmad I. Transition metal complexes as proteasome inhibitors for cancer treatment. Inorg Chim Acta. 2020;506:119521. https:\/\/doi.org\/10.1016\/j.ica.2020.119521.","journal-title":"Inorg Chim Acta"},{"key":"3518_CR26","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.ejmech.2017.11.014","volume":"143","author":"Shagufta","year":"2018","unstructured":"Shagufta, Ahmad I. Tamoxifen\u2013a pioneering drug: an update on the therapeutic potential of tamoxifen derivatives. Eur J Med Chem. 2018;143:515\u2013531. https:\/\/doi.org\/10.1016\/j.ejmech.2017.11.014.","journal-title":"Eur J Med Chem"},{"key":"3518_CR27","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1039\/C7MD00115G","volume":"8","author":"Shagufta","year":"2017","unstructured":"Shagufta, Ahmad I. An insight into the therapeutic potential of quinazoline derivatives as anticancer agents. MedChemComm. 2017;8:871\u2013885. https:\/\/doi.org\/10.1039\/C7MD00115G.","journal-title":"MedChemComm"},{"key":"3518_CR28","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.ejmech.2015.08.047","volume":"102","author":"I Ahmad","year":"2015","unstructured":"Ahmad I, Shagufta. Recent developments in steroidal and nonsteroidal aromatase inhibitors for the chemoprevention of estrogen-dependent breast cancer. Eur J Med Chem. 2015;102:375\u2013386. https:\/\/doi.org\/10.1016\/j.ejmech.2015.08.047.","journal-title":"Eur J Med Chem"},{"key":"3518_CR29","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3390\/biom15030313","volume":"15","author":"H Boo","year":"2025","unstructured":"Boo H, Yoon D, Choi Y, Kim Y, Cha J, Yoo J. Quercetin: molecular insights into its biological roles. Biomolecules. 2025;15:313 https:\/\/doi.org\/10.3390\/biom15030313.","journal-title":"Biomolecules"},{"key":"3518_CR30","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.3390\/ph16071020","volume":"16","author":"F Aghababaei","year":"2023","unstructured":"Aghababaei F, Hadidi M. Recent advances in potential health benefits of quercetin. Pharmaceuticals. 2023;16:1020 https:\/\/doi.org\/10.3390\/ph16071020.","journal-title":"Pharmaceuticals"},{"key":"3518_CR31","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.3390\/molecules29051000","volume":"29","author":"E Carrillo-Martinez","year":"2024","unstructured":"Carrillo-Martinez E, Flores-Hern\u00e1ndez F, Salazar-Montes A, Nario-Chaidez H, Hern\u00e1ndez-Ortega L. Quercetin, a flavonoid with great pharmacological capacity. Molecules. 2024;29:1000 https:\/\/doi.org\/10.3390\/molecules29051000.","journal-title":"Molecules"},{"key":"3518_CR32","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.3390\/app10031147","volume":"10","author":"OO Brovarets\u2019","year":"2020","unstructured":"Brovarets\u2019 OO, Hovorun DM. A never-ending conformational story of the quercetin molecule: quantum-mechanical investigation of the O3\u2032H and O4\u2032H hydroxyl groups rotations. Appl Sci. 2020;10:1147 https:\/\/doi.org\/10.3390\/app10031147.","journal-title":"Appl Sci"},{"key":"3518_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.114068","volume":"229","author":"SR Alizadeh","year":"2022","unstructured":"Alizadeh SR, Ebrahimzadeh MA. Quercetin derivatives: drug design, development, and biological activities \u2013 a review. Eur J Med Chem. 2022;229:114068. https:\/\/doi.org\/10.1016\/j.ejmech.2021.114068.","journal-title":"Eur J Med Chem"},{"key":"3518_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodchem.2024.140262","volume":"458","author":"X Zhu","year":"2024","unstructured":"Zhu X, Ding G, Ren S, Xi J, Liu K. The bioavailability, absorption, metabolism, and regulation of glucolipid metabolism disorders by quercetin and its important glycosides: a review. Food Chem. 2024;458:140262. https:\/\/doi.org\/10.1016\/j.foodchem.2024.140262.","journal-title":"Food Chem"},{"key":"3518_CR35","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.tifs.2016.07.004","volume":"56","author":"W Wang","year":"2016","unstructured":"Wang W, Sun C, Mao L, Ma P, Liu F, Yang J, et al. The biological activities, chemical stability, metabolism and delivery systems of quercetin: a review. Trends Food Sci Technol. 2016;56:21\u201338. https:\/\/doi.org\/10.1016\/j.tifs.2016.07.004.","journal-title":"Trends Food Sci Technol"},{"key":"3518_CR36","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.3390\/biomedicines12061300","volume":"12","author":"JC Hugh","year":"2024","unstructured":"Hugh JC, Haddon LSJ, Githaka JM. DREAM On, DREAM Off: a review of the estrogen paradox in luminal A breast cancers. Biomedicines. 2024;12:1300 https:\/\/doi.org\/10.3390\/biomedicines12061300.","journal-title":"Biomedicines"},{"key":"3518_CR37","doi-asserted-by":"publisher","first-page":"289","DOI":"10.2147\/BTT.S29923","volume":"6","author":"CJ Creighton","year":"2012","unstructured":"Creighton CJ. The molecular profile of luminal B breast cancer. Biologics. 2012;6:289\u2013297. https:\/\/doi.org\/10.2147\/BTT.S29923.","journal-title":"Biologics"},{"key":"3518_CR38","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.3390\/cancers15071987","volume":"15","author":"MF Mercogliano","year":"2023","unstructured":"Mercogliano MF, Bruni S, Mauro FL, Schillaci R. Emerging targeted therapies for HER2-positive breast cancer. Cancers. 2023;15:1987 https:\/\/doi.org\/10.3390\/cancers15071987.","journal-title":"Cancers"},{"key":"3518_CR39","doi-asserted-by":"publisher","first-page":"523","DOI":"10.2147\/BCTT.S516125","volume":"17","author":"A Agelidis","year":"2025","unstructured":"Agelidis A, Ter-Zakarian A, Jaloudi M. Triple-negative breast cancer on the rise: breakthroughs and beyond. Breast Cancer. 2025;17:523\u2013529. https:\/\/doi.org\/10.2147\/BCTT.S516125.","journal-title":"Breast Cancer"},{"key":"3518_CR40","doi-asserted-by":"publisher","first-page":"586","DOI":"10.3390\/biology10070586","volume":"10","author":"I Bhat","year":"2021","unstructured":"Bhat I, Bhat R. Quercetin: a bioactive compound imparting cardiovascular and neuroprotective benefits\u2014scope for exploring fresh produce, their wastes, and by-products. Biology. 2021;10:586 https:\/\/doi.org\/10.3390\/biology10070586.","journal-title":"Biology"},{"key":"3518_CR41","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3892\/or.2017.5703","volume":"38","author":"M Hashemzaei","year":"2017","unstructured":"Hashemzaei M, Far A, Yari A, Heravi R, Tabrizian K, Taghdisi S, et al. Anticancer and apoptosis-inducing effects of quercetin in vitro and in vivo. Oncol Rep. 2017;38:819\u2013828. https:\/\/doi.org\/10.3892\/or.2017.5703.","journal-title":"Oncol Rep"},{"key":"3518_CR42","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1055\/s-0044-1789016","volume":"19","author":"D Afriza","year":"2024","unstructured":"Afriza D, Arma U, Faslah R, Suriyah W. Anticancer potential of quercetin on oral squamous cell carcinoma: a scoping review and molecular docking. Eur J Dent. 2024;19:15\u201323. https:\/\/doi.org\/10.1055\/s-0044-1789016.","journal-title":"Eur J Dent"},{"key":"3518_CR43","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1080\/10942912.2023.2252619","volume":"26","author":"M Shahbaz","year":"2023","unstructured":"Shahbaz M, Naeem H, Momal U, Imran M, Alsagaby S, Abdulmonem A, et al. Anticancer and apoptosis-inducing potential of quercetin against a wide range of human malignancies. Int J Food Prop. 2023;26:2590\u20132626. https:\/\/doi.org\/10.1080\/10942912.2023.2252619.","journal-title":"Int J Food Prop"},{"key":"3518_CR44","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.3390\/molecules26051315","volume":"26","author":"S Almatroodi","year":"2021","unstructured":"Almatroodi S, Alsahli M, Almatroudi A, Verma A, Aloliqi A, Allemailem K, et al. Potential therapeutic targets of quercetin and its role in the therapy of various types of cancer through the modulation of cell-signaling pathways. Molecules. 2021;26:1315 https:\/\/doi.org\/10.3390\/molecules26051315.","journal-title":"Molecules"},{"key":"3518_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1077531","volume":"14","author":"N Lotfi","year":"2023","unstructured":"Lotfi N, Yousefi Z, Golabi M, Khalilian P, Ghezelbash B, Montazeri M, et al. The potential anticancer effects of quercetin on blood, prostate, and lung cancers: an update. Front Immunol. 2023;14:1077531. https:\/\/doi.org\/10.3389\/fimmu.2023.1077531.","journal-title":"Front Immunol"},{"key":"3518_CR46","doi-asserted-by":"publisher","first-page":"529","DOI":"10.3390\/nu8090529","volume":"8","author":"F Khan","year":"2016","unstructured":"Khan F, Niaz K, Maqbool F, Hassan F, Abdollahi M, Venkata K, et al. Molecular targets underlying the anticancer effects of quercetin: an update. Nutrients. 2016;8:529 https:\/\/doi.org\/10.3390\/nu8090529.","journal-title":"Nutrients"},{"key":"3518_CR47","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00289-022-04091-8","volume":"80","author":"M Azeem","year":"2022","unstructured":"Azeem M, Hanif M, Mahmood K, Ameer N, Chughtai F, Abid U. An insight into anticancer, antioxidant, antimicrobial, antidiabetic and anti-inflammatory effects of quercetin: a review. Polym Bull. 2022;80:241\u2013262. https:\/\/doi.org\/10.1007\/s00289-022-04091-8.","journal-title":"Polym Bull"},{"key":"3518_CR48","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.abb.2014.05.030","volume":"557","author":"S Yamazaki","year":"2014","unstructured":"Yamazaki S, Miyoshi N, Kawabata K, Yasuda M, Shimoi K. Quercetin-3-O-glucuronide inhibits noradrenaline-promoted invasion of MDA-MB-231 human breast cancer cells by blocking \u03b2\u2082-adrenergic signaling. Arch Biochem Biophys. 2014;557:18\u201327. https:\/\/doi.org\/10.1016\/j.abb.2014.05.030.","journal-title":"Arch Biochem Biophys"},{"key":"3518_CR49","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1039\/c7fo01964e","volume":"9","author":"Q Wu","year":"2018","unstructured":"Wu Q, Needs PW, Lu Y, Kroon PA, Ren D, Yang X. Different antitumor effects of quercetin, quercetin-3\u2032-sulfate and quercetin-3-glucuronide in human breast cancer MCF-7 cells. Food Funct. 2018;9:1736\u20131746. https:\/\/doi.org\/10.1039\/c7fo01964e.","journal-title":"Food Funct"},{"key":"3518_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-07087-6","volume":"12","author":"SK Shaji","year":"2022","unstructured":"Shaji SK, Drishya G, Sunilkumar D, Suravajhala P, Kumar GB, Nair BG. Systematic understanding of anti-tumor mechanisms of tamarixetin through network and experimental analyses. Sci Rep. 2022;12:3966. https:\/\/doi.org\/10.1038\/s41598-022-07087-6.","journal-title":"Sci Rep"},{"key":"3518_CR51","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/mc.21839","volume":"52","author":"J Li","year":"2013","unstructured":"Li J, Zhu F, Lubet RA, De Luca A, Grubbs C, Ericson ME, et al. Quercetin-3-methyl ether inhibits lapatinib-sensitive and -resistant breast cancer cell growth by inducing G2\/M arrest and apoptosis. Mol Carcinog. 2013;52:134\u2013143. https:\/\/doi.org\/10.1002\/mc.21839.","journal-title":"Mol Carcinog"},{"key":"3518_CR52","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.3892\/ijmm.2018.3741","volume":"42","author":"L Cao","year":"2018","unstructured":"Cao L, Yang Y, Ye Z, Lin B, Zeng J, Li C, et al. Quercetin-3-methyl ether suppresses human breast cancer stem cell formation by inhibiting the Notch1 and PI3K\/Akt signaling pathways. Int J Mol Med. 2018;42:1625\u20131636. https:\/\/doi.org\/10.3892\/ijmm.2018.3741.","journal-title":"Int J Mol Med"},{"key":"3518_CR53","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1002\/ptr.5878","volume":"31","author":"M Iriti","year":"2017","unstructured":"Iriti M, Kubina R, Cochis A, Sorrentino R, Varoni EM, Kabala-Dzik A, et al. Rutin, a quercetin glycoside, restores chemosensitivity in human breast cancer cells. Phytother Res. 2017;31:1529\u20131538. https:\/\/doi.org\/10.1002\/ptr.5878.","journal-title":"Phytother Res"},{"key":"3518_CR54","doi-asserted-by":"publisher","first-page":"7181","DOI":"10.1021\/acs.jafc.8b02420","volume":"66","author":"Q Wu","year":"2018","unstructured":"Wu Q, Kroon PA, Shao H, Needs PW, Yang X. Differential effects of quercetin and two of its derivatives, isorhamnetin and isorhamnetin-3-glucuronide, in inhibiting the proliferation of human breast cancer MCF-7 cells. J Agric Food Chem. 2018;66:7181\u20137189. https:\/\/doi.org\/10.1021\/acs.jafc.8b02420.","journal-title":"J Agric Food Chem"},{"key":"3518_CR55","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3390\/ijms21010131","volume":"21","author":"J Qiu","year":"2019","unstructured":"Qiu J, Zhang T, Zhu X, Yang C, Wang Y, Zhou N, et al. Hyperoside induces breast cancer cells apoptosis via ROS-mediated NF-\u03baB signaling pathway. Int J Mol Sci. 2019;21:131 https:\/\/doi.org\/10.3390\/ijms21010131.","journal-title":"Int J Mol Sci"},{"key":"3518_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.fitote.2019.104191","volume":"137","author":"LM Ma","year":"2019","unstructured":"Ma LM, Xu F, Wang JZ, Shang MY, Liu GX, Cai SQ. In vivo metabolism of 8,2\u2032-diprenylquercetin 3-methyl ether and the distribution of its metabolites in rats by HPLC-ESI-IT-TOF-MSn. Fitoterapia. 2019;137:104191. https:\/\/doi.org\/10.1016\/j.fitote.2019.104191.","journal-title":"Fitoterapia"},{"key":"3518_CR57","doi-asserted-by":"publisher","first-page":"11849","DOI":"10.1021\/acsomega.0c01818","volume":"5","author":"B Salehi","year":"2020","unstructured":"Salehi B, Machin L, Monzote L, Sharifi-Rad J, Ezzat SM, Salem MA, et al. Therapeutic potential of quercetin: new insights and perspectives for human health. ACS Omega. 2020;5:11849\u201311872. https:\/\/doi.org\/10.1021\/acsomega.0c01818.","journal-title":"ACS Omega"},{"key":"3518_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfutfo.2025.01.014","author":"C Bai","year":"2025","unstructured":"Bai C, Hu X, Lu S, Xu B, Ma T, Song Y. Recent advances and application challenges of quercetin-loaded delivery systems: from material selection to bioavailability. J Future Foods. 2025. https:\/\/doi.org\/10.1016\/j.jfutfo.2025.01.014.","journal-title":"J Future Foods"},{"key":"3518_CR59","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.1021\/acs.jafc.6b01056","volume":"64","author":"X Chen","year":"2016","unstructured":"Chen X, Zou L, Liu W, McClements DJ. Potential of excipient emulsions for improving quercetin bioaccessibility and antioxidant activity: an in vitro study. J Agric Food Chem. 2016;64:3653\u20133660. https:\/\/doi.org\/10.1021\/acs.jafc.6b01056.","journal-title":"J Agric Food Chem"},{"key":"3518_CR60","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1039\/c2fo30042g","volume":"4","author":"H Pool","year":"2013","unstructured":"Pool H, Mendoza S, Xiao H, McClements DJ. Encapsulation and release of hydrophobic bioactive components in nanoemulsion-based delivery systems: impact of physical form on quercetin bioaccessibility. Food Funct. 2013;4:162\u2013174. https:\/\/doi.org\/10.1039\/c2fo30042g.","journal-title":"Food Funct"},{"key":"3518_CR61","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/bdd.605","volume":"29","author":"YJ Moon","year":"2008","unstructured":"Moon YJ, Wang L, DiCenzo R, Morris ME. Quercetin pharmacokinetics in humans. Biopharm Drug Dispos. 2008;29:205\u2013217. https:\/\/doi.org\/10.1002\/bdd.605.","journal-title":"Biopharm Drug Dispos"},{"key":"3518_CR62","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1080\/00498254.2018.1509246","volume":"49","author":"C Chalet","year":"2019","unstructured":"Chalet C, Hollebrands B, Duchateau GS, Augustijns P. Intestinal phase-II metabolism of quercetin in HT29 cells, 3D human intestinal tissues and in healthy volunteers: a qualitative comparison using LC-IMS-MS and LC-HRMS. Xenobiotica. 2019;49:945\u2013952. https:\/\/doi.org\/10.1080\/00498254.2018.1509246.","journal-title":"Xenobiotica"},{"key":"3518_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.molliq.2022.120236","volume":"266","author":"NK Bhatia","year":"2022","unstructured":"Bhatia NK, Tomar VR, Ishika N, Kishor S, Deep S. Effect of pH and temperature on physicochemical properties, aggregation behaviour and degradation kinetics of quercetin and baicalein in nearly aqueous media. J Mol Liq. 2022;266:120236. https:\/\/doi.org\/10.1016\/j.molliq.2022.120236.","journal-title":"J Mol Liq"},{"key":"3518_CR64","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s10534-010-9372-7","volume":"24","author":"A P\u0119kal","year":"2011","unstructured":"P\u0119kal A, Biesaga M, Pyrzynska K. Interaction of quercetin with copper ions: complexation, oxidation and reactivity towards radicals. Biometals. 2011;24:41\u201349. https:\/\/doi.org\/10.1007\/s10534-010-9372-7.","journal-title":"Biometals"},{"key":"3518_CR65","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.3390\/ph16111631","volume":"16","author":"MA Mirza","year":"2023","unstructured":"Mirza MA, Mahmood S, Hilles AR, Ali A, Khan MZ, Zaidi SAA, et al. Quercetin as a therapeutic product: evaluation of its pharmacological action and clinical applications: a review. Pharmaceuticals. 2023;16:1631 https:\/\/doi.org\/10.3390\/ph16111631.","journal-title":"Pharmaceuticals"},{"key":"3518_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.ultsonch.2021.105686","volume":"78","author":"MF Manzoor","year":"2021","unstructured":"Manzoor MF, Hussain A, Sameen A, Sahar A, Khan S, Siddique R, et al. Novel extraction, rapid assessment and bioavailability improvement of quercetin: a review. Ultrason Sonochem. 2021;78:105686. https:\/\/doi.org\/10.1016\/j.ultsonch.2021.105686.","journal-title":"Ultrason Sonochem"},{"key":"3518_CR67","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.3390\/nu12082306","volume":"12","author":"V Mohos","year":"2020","unstructured":"Mohos V, Flisz\u00e1r-Ny\u00fal E, Ungv\u00e1ri O, Kuffa K, Needs PW, Kroon PA, et al. Inhibitory effects of quercetin and its main methyl, sulfate, and glucuronic acid conjugates on cytochrome P450 enzymes and on OATP, BCRP and MRP2 transporters. Nutrients. 2020;12:2306 https:\/\/doi.org\/10.3390\/nu12082306.","journal-title":"Nutrients"},{"key":"3518_CR68","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1177\/03008916241261484","volume":"110","author":"H Tang","year":"2024","unstructured":"Tang H, Li YX, Lian JJ, Ng HY, Wang SSY. Personalized treatment using predictive biomarkers in solid organ malignancies: a review. Tumori. 2024;110:386\u2013404. https:\/\/doi.org\/10.1177\/03008916241261484.","journal-title":"Tumori"},{"key":"3518_CR69","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1016\/j.fct.2012.01.025","volume":"50","author":"H Zhang","year":"2012","unstructured":"Zhang H, Zhang M, Yu L, Zhao Y, He N, Yang X. Antitumor activities of quercetin and quercetin-5\u2032,8-disulfonate in human colon and breast cancer cell lines. Food Chem Toxicol. 2012;50:1589\u20131599. https:\/\/doi.org\/10.1016\/j.fct.2012.01.025.","journal-title":"Food Chem Toxicol"},{"key":"3518_CR70","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1016\/j.bmc.2013.01.057","volume":"21","author":"SY Cho","year":"2013","unstructured":"Cho SY, Kim MK, Park KS, Choo H, Chong Y. Quercetin-POC conjugates: differential stability and bioactivity profiles between breast cancer (MCF-7) and colorectal carcinoma (HCT116) cell lines. Bioorg Med Chem. 2013;21:1671\u20131679. https:\/\/doi.org\/10.1016\/j.bmc.2013.01.057.","journal-title":"Bioorg Med Chem"},{"key":"3518_CR71","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.cbi.2015.09.022","volume":"242","author":"H Liao","year":"2015","unstructured":"Liao H, Bao X, Zhu J, Qu J, Sun Y, Ma X, et al. O-alkylated derivatives of quercetin induce apoptosis of MCF-7 cells via a caspase-independent mitochondrial pathway. Chem Biol Interact. 2015;242:91\u201398. https:\/\/doi.org\/10.1016\/j.cbi.2015.09.022.","journal-title":"Chem Biol Interact"},{"key":"3518_CR72","doi-asserted-by":"publisher","first-page":"605","DOI":"10.3390\/cancers14030605","volume":"14","author":"A Lewi\u0144ska","year":"2022","unstructured":"Lewi\u0144ska A, Przybylski P, Adamczyk-Grochala J, B\u0142oniarz D, Litwinienko G, Wnuk M. Senolysis-based elimination of chemotherapy-induced senescent breast cancer cells by quercetin derivative with blocked hydroxy groups. Cancers. 2022;14:605 https:\/\/doi.org\/10.3390\/cancers14030605.","journal-title":"Cancers"},{"key":"3518_CR73","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.3390\/molecules29102408","volume":"29","author":"K Sakao","year":"2024","unstructured":"Sakao K, Hamamoto S, Urakawa D, He Z, Hou DX. Anticancer activity and molecular mechanisms of acetylated and methylated quercetin in human breast cancer cells. Molecules. 2024;29:2408 https:\/\/doi.org\/10.3390\/molecules29102408.","journal-title":"Molecules"},{"key":"3518_CR74","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.jcis.2014.08.064","volume":"436","author":"SR Kumar","year":"2014","unstructured":"Kumar SR, Priyatharshni S, Babu VN, Mangalaraj D, Viswanathan C, Kannan S, et al. Quercetin conjugated superparamagnetic magnetite nanoparticles for in-vitro analysis of breast cancer cell lines for chemotherapy applications. J Colloid Interface Sci. 2014;436:234\u2013242. https:\/\/doi.org\/10.1016\/j.jcis.2014.08.064.","journal-title":"J Colloid Interface Sci"},{"key":"3518_CR75","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.apsusc.2016.03.217","volume":"378","author":"Z\u00dc Akal","year":"2016","unstructured":"Akal Z\u00dc, Alpsoy L, Baykal A. Biomedical applications of SPION@APTES@PEG-folic acid@carboxylated quercetin nanodrug on various cancer cells. Appl Surf Sci. 2016;378:572\u2013581. https:\/\/doi.org\/10.1016\/j.apsusc.2016.03.217.","journal-title":"Appl Surf Sci"},{"key":"3518_CR76","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12296","volume":"49","author":"S Balakrishnan","year":"2016","unstructured":"Balakrishnan S, Bhat FA, Raja Singh P, Mukherjee S, Elumalai P, Das S, et al. Gold nanoparticle-conjugated quercetin inhibits epithelial-mesenchymal transition, angiogenesis and invasiveness via EGFR\/VEGFR-2-mediated pathway in breast cancer. Cell Prolif. 2016;49:e12296. https:\/\/doi.org\/10.1111\/cpr.12296.","journal-title":"Cell Prolif"},{"key":"3518_CR77","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/cbf.3266","volume":"35","author":"S Balakrishnan","year":"2017","unstructured":"Balakrishnan S, Mukherjee S, Das S, Bhat FA, Raja Singh P, Patra CR, et al. Gold nanoparticles-conjugated quercetin induces apoptosis via inhibition of EGFR\/PI3K\/Akt-mediated pathway in breast cancer cell lines (MCF-7 and MDA-MB-231). Cell Biochem Funct. 2017;35:217\u2013231. https:\/\/doi.org\/10.1002\/cbf.3266.","journal-title":"Cell Biochem Funct"},{"key":"3518_CR78","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s00775-019-01749-z","volume":"25","author":"H Mutlu Gen\u00e7kal","year":"2020","unstructured":"Mutlu Gen\u00e7kal H, Erkisa M, Alper P, Sahin S, Ulukaya E, Ari F. Mixed ligand complexes of Co(II), Ni(II) and Cu(II) with quercetin and diimine ligands: synthesis, characterization, anti-cancer and anti-oxidant activity. J Biol Inorg Chem. 2020;25:161\u2013177. https:\/\/doi.org\/10.1007\/s00775-019-01749-z.","journal-title":"J Biol Inorg Chem"},{"key":"3518_CR79","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s12668-024-01767-5","volume":"15","author":"N Abdul-Razek","year":"2025","unstructured":"Abdul-Razek N, Khalil RG, Abdel-Latif M, Mahmoud MK, Ibrahim MA, Ezzat MA, et al. Investigating the tumor-suppressive, antioxidant effects and molecular binding affinity of quercetin-loaded selenium nanoparticles in breast cancer cells. BioNanoSci. 2025;15:135 https:\/\/doi.org\/10.1007\/s12668-024-01767-5.","journal-title":"BioNanoSci"},{"key":"3518_CR80","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.bbrc.2018.04.174","volume":"500","author":"F Aghapour","year":"2018","unstructured":"Aghapour F, Moghadamnia AA, Nicolini A, Mousavi Kani SN, Barari L, Morakabati P, et al. Quercetin conjugated with silica nanoparticles inhibits tumor growth in MCF-7 breast cancer cell lines. Biochem Biophys Res Commun. 2018;500:860\u2013865. https:\/\/doi.org\/10.1016\/j.bbrc.2018.04.174.","journal-title":"Biochem Biophys Res Commun"},{"key":"3518_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2020.111284","volume":"196","author":"M Liu","year":"2020","unstructured":"Liu M, Fu M, Yang X, Jia G, Shi X, Ji J, et al. Paclitaxel and quercetin co-loaded functional mesoporous silica nanoparticles overcoming multidrug resistance in breast cancer. Colloids Surf B Biointerfaces. 2020;196:111284. https:\/\/doi.org\/10.1016\/j.colsurfb.2020.111284.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"3518_CR82","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1016\/j.bbagen.2016.07.001","volume":"1860","author":"A Sarkar","year":"2016","unstructured":"Sarkar A, Ghosh S, Chowdhury S, Pandey B, Sil PC. Targeted delivery of quercetin loaded mesoporous silica nanoparticles to the breast cancer cells. Biochim Biophys Acta. 2016;1860:2065\u20132075. https:\/\/doi.org\/10.1016\/j.bbagen.2016.07.001.","journal-title":"Biochim Biophys Acta"},{"key":"3518_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfa.2024.135914","volume":"707","author":"HVT Nguyen","year":"2025","unstructured":"Nguyen HVT, Mai NXD, Lai HT, Nguyen LHT, Pham QT, Nguyen HV, et al. Targeted, pH-responsive quercetin delivery via hyaluronic acid-functionalized mesoporous nanoparticles for cancer treatment. Colloids Surf A Physicochem Eng Asp. 2025;707:135914. https:\/\/doi.org\/10.1016\/j.colsurfa.2024.135914.","journal-title":"Colloids Surf A Physicochem Eng Asp"},{"key":"3518_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2021.131420","volume":"425","author":"L Shang","year":"2021","unstructured":"Shang L, Yang T, Yang C, Li Z, Kong L, Zhang Z. Metal ions-mediated self-assembly of nanomedicine for combinational therapy against triple-negative breast cancer. Chem Eng J. 2021;425:131420. https:\/\/doi.org\/10.1016\/j.cej.2021.131420.","journal-title":"Chem Eng J"},{"key":"3518_CR85","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ijbiomac.2021.06.085","volume":"185","author":"AM Elsayed","year":"2021","unstructured":"Elsayed AM, Sherif NM, Hassan NS, Althobaiti F, Hanafy NAN, Sahyon HA. Novel quercetin encapsulated chitosan functionalized copper oxide nanoparticles as anti-breast cancer agent via regulating p53 in rat model. Int J Biol Macromol. 2021;185:134\u2013152. https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.06.085.","journal-title":"Int J Biol Macromol"},{"key":"3518_CR86","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ejpb.2018.08.009","volume":"131","author":"R de Oliveira Pedro","year":"2018","unstructured":"de Oliveira Pedro R, Hoffmann S, Pereira S, Goycoolea FM, Schmitt CC, Neumann MG. Self-assembled amphiphilic chitosan nanoparticles for quercetin delivery to breast cancer cells. Eur J Pharm Biopharm. 2018;131:203\u2013210. https:\/\/doi.org\/10.1016\/j.ejpb.2018.08.009.","journal-title":"Eur J Pharm Biopharm"},{"key":"3518_CR87","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1039\/d1ra05382e","volume":"12","author":"M Matiyani","year":"2022","unstructured":"Matiyani M, Rana A, Pal M, Rana S, Melkani AB, Sahoo NG. Polymer grafted magnetic graphene oxide as a potential nanocarrier for pH-responsive delivery of sparingly soluble quercetin against breast cancer cells. RSC Adv. 2022;12:2574\u20132588. https:\/\/doi.org\/10.1039\/d1ra05382e.","journal-title":"RSC Adv"},{"key":"3518_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2023.135059","volume":"1281","author":"M Safari","year":"2023","unstructured":"Safari M, Naseri M, Esmaeili E, Naderi E. Green synthesis by celery seed extract and improvement of the anticancer activity of quercetin-loaded rGO\/Ca1-xMnxFe2O4 nanocarriers using UV light in breast cancer cells. J Mol Struct. 2023;1281:135059. https:\/\/doi.org\/10.1016\/j.molstruc.2023.135059.","journal-title":"J Mol Struct"},{"key":"3518_CR89","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1039\/d4ma01202j","volume":"6","author":"S Sunoqrot","year":"2025","unstructured":"Sunoqrot S, Abusulieh S, Dahabiyeh LA. Insights into the anticancer and anti-inflammatory activities of curcumin-loaded quercetin nanoparticles: in vitro bioassays coupled with synchrotron infrared microspectroscopy. Mater Adv. 2025;6:1971\u20131987. https:\/\/doi.org\/10.1039\/d4ma01202j.","journal-title":"Mater Adv"},{"key":"3518_CR90","doi-asserted-by":"publisher","first-page":"9155","DOI":"10.2147\/IJN.S518174","volume":"20","author":"ZY Wu","year":"2025","unstructured":"Wu ZY, Qiu KY, Gai YJ, Wu JH, Zhou BX, Shi QF. Quercetin: a natural ally in combating breast cancer. Int J Nanomed. 2025;20:9155\u20139177. https:\/\/doi.org\/10.2147\/IJN.S518174.","journal-title":"Int J Nanomed"},{"key":"3518_CR91","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.3390\/ijms24032952","volume":"24","author":"A Maugeri","year":"2023","unstructured":"Maugeri A, Calderaro A, Patan\u00e8 GT, Navarra M, Barreca D, Cirmi S, et al. Targets involved in the anti-cancer activity of quercetin in breast, colorectal and liver neoplasms. Int J Mol Sci. 2023;24:2952 https:\/\/doi.org\/10.3390\/ijms24032952.","journal-title":"Int J Mol Sci"},{"key":"3518_CR92","unstructured":"ClinicalTrials.gov. Dasatinib Combined With Quercetin to Reverse Chemo Resistance in Triple Negative Breast Cancer. Identifier NCT06355037. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT06355037."},{"key":"3518_CR93","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13765-025-01063-0","volume":"68","author":"J Cho","year":"2025","unstructured":"Cho J, Kim K, Lee JG. Quercetin in food: structure, biosynthesis, toxicity, analytical method, occurrence and risk assessments. Appl Biol Chem. 2025;68:90 https:\/\/doi.org\/10.1186\/s13765-025-01063-0.","journal-title":"Appl Biol Chem"},{"key":"3518_CR94","doi-asserted-by":"publisher","first-page":"269","DOI":"10.18502\/pbr.v6i4.5113","volume":"6","author":"NI Dibal","year":"2021","unstructured":"Dibal NI, Hyedima Garba S, Watson Jacks T. Acute toxicity of quercetin from onion skin in mice. Pharm Biomed Res. 2021;6:269\u2013276. https:\/\/doi.org\/10.18502\/pbr.v6i4.5113.","journal-title":"Pharm Biomed Res"},{"key":"3518_CR95","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/toxsci\/19.3.423","volume":"19","author":"JK Dunnick","year":"1992","unstructured":"Dunnick JK, Halley JR. Toxicity and carcinogenicity studies of quercetin, a natural component of foods. Fundam Appl Toxicol. 1992;19:423\u2013431. https:\/\/doi.org\/10.1093\/toxsci\/19.3.423.","journal-title":"Fundam Appl Toxicol"},{"key":"3518_CR96","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/j.1439-0272.2001.tb01496.x","volume":"33","author":"KL Khanduja","year":"2001","unstructured":"Khanduja KL, Verma A, Bhardwaj A. Impairment of human sperm motility and viability by quercetin is independent of lipid peroxidation. Andrologia. 2001;33:277\u2013281. https:\/\/doi.org\/10.1111\/j.1439-0272.2001.tb01496.x.","journal-title":"Andrologia"},{"key":"3518_CR97","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1016\/j.fct.2007.05.015","volume":"45","author":"M Harwood","year":"2007","unstructured":"Harwood M, Danielewska-Nikiel B, Borzelleca JF, Flamm GW, Williams GM, Lines TC. A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic\/carcinogenic properties. Food Chem Toxicol. 2007;45:2179\u20132205. https:\/\/doi.org\/10.1016\/j.fct.2007.05.015.","journal-title":"Food Chem Toxicol"},{"key":"3518_CR98","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/S0278-6915(02)00015-7","volume":"40","author":"J Da Silva","year":"2002","unstructured":"Da Silva J, Herrmann SM, Heuser V, Peres W, Possa Marroni N, Gonz\u00e1lez-Gallego J, et al. Evaluation of the genotoxic effect of Rutin and Quercetin by comet assay and micronucleus test. Food Chem Toxicol. 2002;40:941\u20137.","journal-title":"Food Chem Toxicol"},{"key":"3518_CR99","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1002\/tox.22983","volume":"35","author":"Z Xu","year":"2020","unstructured":"Xu Z, Zhao D, Zheng X, Huang B, Xia X, Pan X. Quercetin exerts bidirectional regulation effects on the efficacy of tamoxifen in estrogen receptor-positive breast cancer therapy: an in vitro study. Env Toxicol. 2020;35:1179\u20131193. https:\/\/doi.org\/10.1002\/tox.22983.","journal-title":"Env Toxicol"},{"key":"3518_CR100","doi-asserted-by":"publisher","DOI":"10.1002\/cnr2.70220-","volume":"8","author":"J Zhang","year":"2025","unstructured":"Zhang J, Guo J, Qian Y, Yu L, Ma J, Gu B, et al. Quercetin induces apoptosis through downregulating P4HA2 and inhibiting the PI3K\/Akt\/mTOR axis in hepatocellular carcinoma cells: an in vitro study. Cancer Rep. 2025;8. e70220. https:\/\/doi.org\/10.1002\/cnr2.70220-.","journal-title":"Cancer Rep"},{"key":"3518_CR101","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1177\/87551225221125667","volume":"38","author":"R Patel","year":"2022","unstructured":"Patel R, Stine A, Zitko K. Enhanced anticoagulant effect of warfarin when co-administered with quercetin. J Pharm Technol. 2022;38:374\u2013375. https:\/\/doi.org\/10.1177\/87551225221125667.","journal-title":"J Pharm Technol"}],"container-title":["Medicinal Chemistry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00044-025-03518-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00044-025-03518-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00044-025-03518-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T07:48:00Z","timestamp":1777276080000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00044-025-03518-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,3]]},"references-count":101,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["3518"],"URL":"https:\/\/doi.org\/10.1007\/s00044-025-03518-x","relation":{},"ISSN":["1054-2523","1554-8120"],"issn-type":[{"value":"1054-2523","type":"print"},{"value":"1554-8120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,3]]},"assertion":[{"value":"29 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"During the preparation of this work the author(s) used \u201cGrammarly\u201d in order to ensure proper grammar and enhance the article's readability. After using this tool\/service, the author(s) reviewed and edited the content as needed and take(s) full responsibility for the content of the publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration"}}]}}